Covid Study Recruitment

Are you a NYC healthcare worker suffering with stress and burnout?

If so, you may be eligible for MDMA-assisted therapy

After long periods of exposure to stressful, potentially life-

threatening work conditions and traumatic loss, healthcare workers (HCWs) can experience stress-related symptoms that seriously impact their well-being and lead to professional burnout.

Our study uses MDMA-assisted therapy to treat stress- related disorders in HCWs affected by their work on the frontlines of the COVID-19 pandemic in New York City. This single-site, open-label study assesses the effectiveness and safety of a 2-dose protocol in reducing symptoms of subsyndromal or mild Post-Traumatic Stress Disorder and professional burnout in HCWs.

Participants will receive:

• Medical screening, blood tests, ECG.
• Psychiatric screening
• 30 hours of psychotherapy, consisting of 14 hours of non-drug therapy along with 2 all-day (8-hour) drug-assisted therapy sessions. The average length of treatment is 10 weeks.

Are you eligible?

• Must be 18 and understand English
• Live within 60 miles of New York City
• Be in good physical health
• Have a strong social support system
• Be willing to taper off current psychiatric medications
• Do NOT have bipolar disorder or a history of psychosis
• Do NOT have uncontrolled hypertension

Lower East Side of Manhattan.

On-site appointment is required during screening for medical evaluation.

Other study visits can be done remotely except for 2 all-day dosing visits

Location

Are you’re interested in participating or learning more?

Please reach out to:



Drew Ribadeneyra, MA, Study Coordinator

dribadeneyra@mdma.nyc